(Q34136122)

31 July 2017

title

Restless legs syndrome: understanding its consequences and the need for better treatment (English)

1 reference

31 July 2017

Restless legs syndrome: Understanding its consequences and the need for better treatment (English)

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

7 July 2024

main subject

restless legs syndrome

0 references

1

Christopher J Earley

1 reference

31 July 2017

Michael H. Silber

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20817595

7 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20817595

7 July 2024

publication date

1 October 2010

1 reference

full work available at URL

31 July 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:S138994571000290X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

https://api.elsevier.com/content/article/PII:S138994571000290X?httpAccept=text/plain

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

7 July 2024

1 reference

31 July 2017

volume

11

1 reference

31 July 2017

issue

9

1 reference

31 July 2017

page(s)

807-815

1 reference

Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health

31 July 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria.

7 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Cerebral generators involved in the pathogenesis of the restless legs syndrome

7 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome

7 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

The genetics of sleep disorders in humans: narcolepsy, restless legs syndrome, and obstructive sleep apnea syndrome

7 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Restless legs syndrome prevalence and impact: REST general population study

7 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Restless legs syndrome: a community-based study of prevalence, severity, and risk factors

7 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Epidemiology of restless legs syndrome in French adults: a nationwide survey: the INSTANT Study.

7 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Restless legs syndrome symptoms in primary care: a prevalence study.

7 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll.

7 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Physician-diagnosed restless legs syndrome in a large sample of primary medical care patients in western Europe: Prevalence and characteristics

7 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Evaluating the quality of life of patients with restless legs syndrome.

7 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Sex and the risk of restless legs syndrome in the general population

7 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Burden of restless legs syndrome on health-related quality of life.

7 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Restless legs syndrome prevalence and impact: REST general population study

7 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

7 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Is there a need for long-term follow-up in chronic idiopathic polyneuropathy?

7 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Restless legs syndrome, periodic limb movements in sleep, and depression

7 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Depressive disorders in restless legs syndrome: epidemiology, pathophysiology and management

7 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly.

7 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Sleep disturbances and depression in the elderly in Japan

7 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

"Anxietas tibiarum". Depression and anxiety disorders in patients with restless legs syndrome.

7 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms.

7 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Prevalence of restless legs syndrome and periodic limb movement disorder in the general population

7 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort.

7 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study

7 July 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Nocturnal blood pressure changes in patients with restless legs syndrome.

7 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Review of the relationship of restless legs syndrome and periodic limb movements in sleep to hypertension, heart disease, and stroke

7 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Efficacy of pramipexole in restless legs syndrome: a six-week, multicenter, randomized, double-blind study (effect-RLS study)

7 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries

7 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study

7 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Efficacy and safety of pramipexole in restless legs syndrome.

7 July 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Long-term treatment of restless legs syndrome with dopamine agonists

7 July 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Pramipexole in the management of restless legs syndrome: an extended study

7 July 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Long-term treatment with pramipexole in restless legs syndrome.

7 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome

7 July 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Safety of pramipexole in patients with restless legs syndrome

7 July 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute

7 July 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Augmentation of the restless legs syndrome with carbidopa/levodopa.

7 July 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Progressive development of augmentation during long-term treatment with levodopa in restless legs syndrome: results of a prospective multi-center study

7 July 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Restless legs syndrome augmentation and pramipexole treatment

7 July 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS).

7 July 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

The severity range of restless legs syndrome (RLS) and augmentation in a prospective patient cohort: association with ferritin levels

7 July 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Augmentation in restless legs syndrome is associated with low ferritin

7 July 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Prevalence of repetitive and reward-seeking behaviors in Parkinson disease

7 July 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson disease

7 July 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Dopamine agonist-induced pathological gambling in restless legs syndrome due to multiple sclerosis

7 July 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Pathological gambling associated with dopamine agonist use in restless legs syndrome

7 July 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

A case of compulsive behaviors observed in a restless legs syndrome patient treated with a dopamine agonist

7 July 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome

7 July 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Predictors of impulsivity and reward seeking behavior with dopamine agonists

7 July 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study

7 July 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Reduced dopamine transporter density in the ventral striatum of patients with Parkinson's disease and pathological gambling

7 July 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: a double-blind, placebo-controlled pilot study

7 July 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Functional abnormalities underlying pathological gambling in Parkinson disease

7 July 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

At-risk for pathological gambling: imaging neural reward processing under chronic dopamine agonists.

7 July 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study

7 July 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder.

7 July 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Valvular heart disease in Parkinson's disease patients treated with dopamine agonists: a reader-blinded monocenter echocardiography study

7 July 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Dopamine agonists and the risk of cardiac-valve regurgitation

7 July 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Dopamine agonists and cardiac valvulopathy in Parkinson disease: a case-control study

7 July 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial

7 July 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo.

7 July 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Long-term follow-up on restless legs syndrome patients treated with opioids.

7 July 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Sleep-disordered breathing and chronic opioid therapy

7 July 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Restless legs syndrome augmentation associated with tramadol.

7 July 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study

7 July 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

A crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients

7 July 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trial

7 July 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

The treatment of the restless legs syndrome with clonazepam: a prospective controlled study

7 July 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Clonazepam and vibration in restless legs syndrome.

7 July 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

A randomized, double-blind placebo-controlled trial of iron in restless legs syndrome.

7 July 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: A randomized, double-blind, placebo-controlled study

7 July 2024

81

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome

7 July 2024

82

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

A randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome

7 July 2024

83

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Restless legs syndrome: a clinical study of 55 patients.

7 July 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study.

7 July 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Prevalence, severity and risk factors of restless legs syndrome in the general adult population in two Scandinavian countries.

7 July 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Comorbidity in restless legs syndrome among a sample of Swedish adults

7 July 2024

87

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Restless legs syndrome and its relationship with insomnia symptoms and daytime distress: epidemiological survey in Sweden

7 July 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

EEG mapping, psychometric, and polysomnographic studies in restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) patients as compared with normal controls

7 July 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Polysomnography findings in patients with restless legs syndrome and in healthy controls: a comparative observational study.

7 July 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Self-reported depressive symptomatology, mood ratings, and treatment outcome in sleep disorders patients

7 July 2024

92

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Restless legs syndrome in 218 patients: associated disorders.

7 July 2024

93

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Sleep disorders and depressive feelings: a global survey with the Beck depression scale

7 July 2024

94

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey

7 July 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community

7 July 2024

96

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.07.007

7 July 2024

Identifiers

1 reference

31 July 2017

1 reference